Pfizer pills likely to be approved first… Expected to be introduced in the middle of next month


The Korean government started reviewing whether Pfizer’s edible coronavirus treatment, which was approved for emergency use in the United States, can be used in Korea yesterday (23rd). Currently, a treatment made by Merck is also under review for emergency use, and it is expected that an oral treatment will be available from the middle of next month at the earliest.

Reporter Kim Deok-hyun reports.

Last month, the government pre-purchased edible corona treatment supplies for 404,000 people.

As a result of the coverage, it was confirmed as a result of the coverage that Merck’s LaGebrio supplies were secured for 264,000 people and Pfizer’s Pax Lovid was secured for 140,000 people.

The Ministry of Food and Drug Safety began reviewing emergency use approval for Pax Lovid following Lagevrio.

After reviewing relevant data such as effects and side effects, the final approval is decided through expert advisory meetings, etc.

Paxrovid is expected to complete the approval process within the year.

However, the approval of La Gabrio may pass early next year.

As Merck downgraded the severe prevention effect of Laguebrio from 50% to 30%, the quarantine authorities explain that more effectiveness review is needed.

The government is setting the introduction date for early next year, but depending on the outcome of the negotiations, it could be around mid-January at the earliest.

The government has announced that it will take full advantage of the benefits of oral medicines.

[김옥수/중앙방역대책본부 자원지원팀장 : 주사제가 아니어서 재택 환자들에게 매우 유용한 수단이 될 것으로 판단하고 있고 고위험·경증·중등증 환자를 치료하는 병원에서 사용될 것으로….]

The government is also pursuing a plan to purchase more edible medicines.

However, as we saw with the vaccine, the initial quantity is limited and thorough preparation is necessary as countries around the world are competing to purchase ahead of time.

Leave a Reply

Your email address will not be published. Required fields are marked *